NCT03501576 2026-02-11
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Emory University
Recruiting
Clinical Trials
11 trialsNCT05170399 2026-02-05
Vaccine Responses in Patients With B Cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 4 Recruiting
NCT02518555 2026-01-07
Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT03016806 2025-10-10
Umbilical Cord Blood Transplantation From Unrelated Donors
University of Rochester
Recruiting
NCT01949129 2024-01-16
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
St. Anna Kinderkrebsforschung
Phase 2/3 Recruiting
NCT05322330 2023-02-09
Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT04626765 2020-11-13
CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia
Hebei Senlang Biotechnology Inc., Ltd.
Phase EARLY_PHASE1 Unknown
NCT03701438 2020-02-20
Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib
Gilead Sciences
Terminated
NCT02566265 2019-01-30
SHIVERING 2
Yale University
Phase 2 Completed
NCT01135329 2018-07-03
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT00596336 2017-04-12
CLLIFVAC
The Royal Bournemouth Hospital
Phase 2 Terminated